NCAscreen version 0.6

  • Research type

    Research Study

  • Full title

    Neurocognitive assessment of neuroinflammatory disorders - a pilot study

  • IRAS ID

    258420

  • Contact name

    Amit Mistri

  • Contact email

    amit.mistri@uhl-tr.nhs.uk

  • Sponsor organisation

    University Hospital of Leicester NHS Trust

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    Research Summary

    Neuroinflammatory diseases are a group of disorders such as multiple sclerosis, autoimmune encephalitis, neuromyelitis optica which can be very disabling in the individuals who suffer from these conditions. Neurologists normally manage and treat these disorders according to the effect on physical health: such as changes in vision, effect on movements, co-ordination, sensation and seizures. However there is evidence for most of the neuroinflammatory disease that these may also effect cognitive processes such as memory, understanding and learning and emotional wellbeing. For the most part these have not been investigated systematically, nor has it been investigated whether the different neuroinflammatory conditions effect these in a different way.

    Therefore this study proposes to assess the basic cognitive function of patients who have been diagnosed with the neuroinflammatory disorders. We will use a simple tool on an iPad to test cognition as well as some pen and paper questionnaires to screen for emotional well-being. This may guide us to whether routine baseline cognitive and mood assessment would help in the long term management of such patients and whether such a tool is feasible in clinical practice.

    Summary of Results

    Recruitment not feasible in the context of ongoing COVID pandemic.

  • REC name

    North of Scotland Research Ethics Committee 2

  • REC reference

    20/NS/0114

  • Date of REC Opinion

    23 Nov 2020

  • REC opinion

    Further Information Favourable Opinion